Open AccessEntecavir as treatment for reactivation of hepatitis B in immunosuppressed patients
Author(s) -
S Brost
Publication year - 2010
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v16.i43.5447
Subject(s) - entecavir , medicine , hbsag , immunosuppression , hepatitis b , seroconversion , hepatitis b virus , gastroenterology , immunology , lamivudine , antibody , virus
To study the efficacy and safety of entecavir (ETV) as first-line therapy for hepatitis B virus (HBV) reactivation due to immunosuppression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom